A new treatment for obesity

On June 4, 2021, the Food and drug administration announced the extended-predicted approval of Wegovy, an injectable treatment taken after for every 7 days for body weight management.

Wegovy gained substantial media attention in the months preceding approval, with a New York Occasions post declaring it a “video game changer,” MedPage Currently reporting its “unparalleled results,” and the BBC saying it could mark a “new period” in managing obesity. Ongoing media protection proceeds to extol the efficacy of Wegovy as greater than any other medication presently on the industry for body weight administration. This kind of sensational headlines are commonplace

Read more

Wegovy’s Promise As An Effective Treatment For Obesity Now Depends On Insurers : Shots

Health conditions exacerbated by obesity include heart disease, stroke, Type 2 diabetes and certain types of cancer, according to the CDC. Researchers say the newly approved drug Wegovy could help many who struggle with obesity lose weight.

adamkaz/Getty Images


hide caption

toggle caption

adamkaz/Getty Images


Health conditions exacerbated by obesity include heart disease, stroke, Type 2 diabetes and certain types of cancer, according to the CDC. Researchers say the newly approved drug Wegovy could help many who struggle with obesity lose weight.

adamkaz/Getty Images

When a promising new drug to treat obesity was approved by the Food and Drug Administration

Read more